January 12, 2012
Eli Lilly & Co. secured approval Thursday of a $4.5 million settlement of claims brought by an insurer and five union health funds claiming they overpaid for the blockbuster antipsychotic drug Zyprexa because Lilly didn't reveal its adverse side effects.
April 30, 2009
At a hearing Friday in the Zyprexa multidistrict litigation, counsel for a class of third-party payors urged the court to divulge the names of physicians who may have overprescribed the drug at the behest of Eli Lilly & Co. representatives, while the pharmaceutical company argued the identities were immaterial to the case.
April 18, 2008
Attorneys in the multidistrict litigation over AstraZeneca LP's anti-psychotic drug Seroquel have subpoenaed a special settlement master in the separate MDL over Eli Lilly & Co.'s drug Zyprexa, seeking records for plaintiffs who are taking part in both cases.
March 07, 2008
Eli Lilly & Co. was hit with a new lawsuit Thursday over its controversial anti-psychotic drug Zyprexa, this time filed by the state of Connecticut.
January 02, 2008
A federal judge overseeing a slew of product liability cases over Eli Lilly & Co.'s blockbuster anti-psychotic drug Zyprexa is seeking to shut down suits that have reportedly been settled but remain on the court's dockets.